Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026
Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the second quarter of fiscal 2026, for the three months ended December 31, 2025. Fiscal Second Quarter 2026 Financial Results Revenue of $20.3 million versus $41.8 million for the second quarter of fiscal 2025. Gross profit of $3.5 million compared to $7.7 million for the second quarter of fiscal 2025. Gross margin of 17.1% compared to 18.5% for the second quarter of fiscal 2025. Total operating expenses of $10.3 million compared to $15.1 million for the second quarter of fiscal 2025. Net loss of $6.6 million, compared to net loss of $8.0 million in the second quarter of fiscal 2025. "This quarter represented an inflection point for Ispire during its yearlong cost cutting and customer quality rationalization efforts and we believe future quarters will see top line growth, consistent cash flows and bottom-line improvement. We are confident we have laid a solid foundation for future success," commented Michael Wang, Co-Chief Executive Officer of Ispire. "During the second quarter of fiscal 2026, we maintained our focus on prioritizing high-quality revenue, and reinforcing our disciplined and intentional approach to sustainable growth. This was particularly evident in our efforts to reduce net accounts receivable, which continues to have strong success. Over the second fiscal quarter we reduced net accounts receivable by 19.5% to $37.9 million, compared to $47.0 million at the end of fiscal year 2025." "We continue to lay important groundwork across core areas of the business, including the ramp up of our manufacturing capabilities in Malaysia as we prepare to increase production throughout fiscal 2026. Momentum continues to build for our proprietary G-Mesh technology, with several large and mid-sized nicotine manufacturers engaged in discussions to evaluate its use in next-generation vaping devices, as we work toward potential licensing and partnership opportunities. In addition, our IKE Tech joint venture is making steady global progress, collaborating with regulators across Europe, Southeast Asia, and the Middle East to support the broader adoption of age-gating technology as a safer industry standard. In the US, although most adult consumers want flavored e-cigarettes, nearly all of the flavored e-cigarettes are both unauthorized by the FDA and sold through illicit channels. While we welcome the US Federal Government's strengthened enforcement mandate of the illicit trade of vapes, we believe that such enforcement can only be truly effective by pairing it with the creation of a robust, legal market of FDA authorized flavored e-cigarette products. Ispire, with IKE, is a key player in the creation of this market of legal, approved products, using its technologies to both prevent youth-access, ensure product authenticity and provide solutions to secure devices before misuse occurs. This is where we are seeing macro tailwinds in our favor relating to the US FDA's stated position on flavored ENDS products and age-gating. Since October 2025, the FDA's explicit position is that you must have age gating technology if you want flavored products approved. Ispire, through its IKE joint venture, has one of the leading and most low friction technologies in this space, and we look forward to capitalizing on this opportunity in due time", Mr. Wang concluded. Jay Yu, Chief Financial Officer of Ispire, said, "The second quarter of fiscal 2026 reflects continued progress as we focused on strengthening the Company's financial foundation. Disciplined cost controls drove a year-over-year decline in operating expenses, which decreased from $15.1 million to $10.3 million over the second fiscal quarter, highlighting the impact of our efficiency initiatives. Our net accounts receivable also declined to $37.9 million as of December 31, 2025, compared with $47.0 million as of June 30, 2025, reflecting our ongoing focus on higher-quality customers. These actions position the Company for enhanced financial flexibility and support sustained value creation over the long term." Financial Results for the Fiscal Second Quarter Ended December 31, 2025 Ispire reported revenue of $20.3 million for the fiscal second quarter ended December 31, 2025, versus $41.8 million for the prior comparable period. The decrease in revenue is due to the strategic shift away from lower quality cannabis customers, resulting in a decrease of overall product sales. For the second quarter of fiscal 2026, gross profit was $3.5 million compared to $7.7 million in the prior comparable quarter. Gross margin was 17.1% compared to 18.5% for the second quarter of fiscal 2025. The decrease in gross margin was primarily due to changes in product mix with less higher margin products being sold during the three months ended December 31, 2025. Total operating expenses were $10.3 million for the second fiscal quarter of 2026, compared to $15.1 million for the same period last year. Net loss was $6.6 million or $0.12 per share for the fiscal second quarter of 2026, versus a net loss of $8.0 million, or $0.14 per share for the fiscal second quarter of 2025. At December 31, 2025, Ispire held cash of $17.6 million and working capital of $3.5 million. Conference Call The Company will conduct a conference call at 8:00 am ET on Friday, February 6, 2026, to discuss the results, followed by a Q&A session. To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call." Date: Friday, February 6, 2026 Time: 8:00 am ET Dial-In Numbers: United States 877-451-6152 or International +1 201-389-0879 This conference call will be webcast live and can be accessed by all interested parties at https://viavid.webcasts.com/starthere.jsp?ei=1749224&tp_key=1ec45fe266. Please access the link at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software. A playback will be available until 11:59 pm ET on Friday, February 20, 2026. To listen, please dial 1-844-512-2921 or 1-412-317-6671. Use the passcode 13758138 to access the replay. About Ispire Technology Inc.Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Twitter and YouTube. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company will be successful in its plans to further expand into the African market; whether the Company's joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the "Joint Venture") may be successful in achieving its goals as currently contemplated, with different terms, or at all; the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company's ability to collect its accounts receivable in a timely manner; the Company's business strategies; the ability of the Company to market to the Ispire ONETM; Ispire ONETM's success in meeting its goals; the ability of its customers to derive the anticipated benefits of the Ispire ONETM and the success of its products on the markets; the Ispire ONETM proving to be safe; and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2025 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect. ISPIRE TECHNOLOGY INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS(In $USD, except share and per share data) December 31,2025 June 30,2025 Assets Current assets: Cash $ 17,565,334 $ 24,351,765 Restricted cash 50,000 - Accounts receivable, net 37,878,353 39,664,145 Inventories 5,037,414 6,647,970 Prepaid expenses and other current assets 3,120,978 2,244,505 Total current assets 63,652,079 72,908,385 Non-current assets: Accounts receivable, net of current portion - 7,367,158 Property, plant and equipment, net 2,599,861 2,952,800 Intangible assets, net 2,474,037 2,232,620 Right-of-use assets – operating leases 4,335,355 5,030,005 Other investment 2,000,000 2,000,000 Equity method investment 9,129,213 9,515,546 Other non-current assets 210,617 210,617 Total non-current assets 20,749,083 29,308,746 Total assets $ 84,401,162 $ 102,217,131 Liabilities and stockholders' equity Current liabilities Accounts payable $ 3,137,235 $ 4,172,476 Accounts payable – related party 42,444,624 52,420,256 Contract liabilities 4,971,135 4,861,250 Accrued liabilities and other payables 6,818,397 8,099,991 Income tax payable 12,590 - Borrowing – current portion 1,146,766 1,146,766 Operating lease liabilities – current portion 1,659,698 1,838,815 Total current liabilities 60,190,445 72,539,554 Non-current liabilities: Amount due to a related party 29,000,000 25,000,000 Borrowing – net of current portion 231,978 805,361 Operating lease liabilities – net of current portion 2,642,156 3,267,522 Total non-current liabilities 31,874,134 29,072,883 Total liabilities 92,064,579 101,612,437 Commitments and contingencies Stockholders' (deficit)/equity: Common stock, par value $0.0001 per share; 140,000,000 shares authorized; 57,289,864 and 57,193,734 shares issued and outstanding as of December 31, 2025 and June 30, 2025 5,729 5,719 Treasury stock, at cost (105,489) (60,488) Additional paid-in capital 50,593,580 48,833,601 Accumulated deficit (57,927,041) (48,065,267) Accumulated other comprehensive loss (230,196) (108,871) Total stockholders' (deficit)/equity (7,663,417) 604,694 Total liabilities and stockholders' (deficit)/equity $ 84,401,162 $ 102,217,131 ISPIRE TECHNOLOGY INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ANDCOMPREHENSIVE LOSS(In $USD, except share and per share data) Three Months EndedDecember 31, Six Months EndedDecember 31, 2025 2024 2025 2024 Revenue $ 20,286,556 $ 41,827,860 $ 50,637,440 $ 81,166,173 Cost of revenue 16,811,955 34,105,289 42,016,067 65,769,224 Gross profit 3,474,601 7,722,571 8,621,373 15,396,949 Operating expenses: Sales and marketing expenses 1,476,328 2,061,664 3,041,172 5,053,911 Credit loss expenses 4,209,201 4,183,998 5,973,453 7,286,079 General and administrative expenses 4,663,939 8,836,964 9,176,924 15,679,883 Total Operating expenses 10,349,468 15,082,626 18,191,549 28,019,873 Loss from operations (6,874,867) (7,360,055) (9,570,176) (12,622,924) Other income (expense): Interest income 104,922 59,755 200,394 59,841 Interest expense (100,191) (13,073) (212,367) (24,537) Exchange gain (loss), net 290,237 (245,173) 300,039 (127,588) Other income, net 83,574 19,934 12,991 38,333 Total Other income (expense), net 378,542 (178,557) 301,057 (53,951) Loss before income taxes (6,496,325) (7,538,612) (9,269,119) (12,676,875) Income taxes (106,586) (460,031) (592,655) (916,784) Net loss $ (6,602,911) $ (7,998,643) $ (9,861,774) $ (13,593,659) Other comprehensive income (loss) Foreign currency translation adjustments (113,433) 73,470 (121,325) (81,467) Comprehensive loss $ (6,716,344) $ (7,925,173) $ (9,983,099) $ (13,675,126) Net loss per share Basic and diluted $ (0.12) $ (0.14) $ (0.17) $ (0.24) Weighted average shares outstanding: Basic and diluted 57,258,218 56,658,012 57,257,938 56,629,666 For more information, kindly contact: IR Contacts:KCSA Strategic CommunicationsPhil Carlson212-896-1233ispire@kcsa.comPR Contact:Ellen Mellody570-209-2947EMellody@kcsa.com
2026-02-06 12:00:00
Bağlantılar
Oyunlar
İnternette ara
Analitik
Ücretsiz e-posta / Web postası
İnternet mağazası
Ücretsiz alt alan
Küçük URL
ChatGPT
Aletler
Web dizini
wiki
Ulaşım
Kitabın
Gündem
Kişiler
Müzik